We are live on ! Find out more
BIVI icon

BioVie
BIVI

36 hedge funds and large institutions have $2.86M invested in BioVie in 2026 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

98% more capital invested

Capital invested by funds: $1.44M → $2.86M (+$1.41M)

9% more funds holding

Funds holding: 33 → 36 (+3)

5.85% more ownership

Funds ownership: 13.67% → 19.52% (+5.8%)

27% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 11

Holders
36
Holders Change
+3
Holders Change %
+9.09%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
8
Reduced
11
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$833K
2
Renaissance Technologies
Renaissance Technologies
New York
+$94.2K
3
Citadel Advisors
Citadel Advisors
Florida
+$79.6K
4
PAP
Persistent Asset Partners
Hong Kong
+$23.6K
5
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
+$21.7K

Top Sellers

Rank Fund Capital Flow
1
DC
Diametric Capital
Massachusetts
-$178K
2
PCM
Prelude Capital Management
New York
-$93.4K
3
PTC
Philadelphia Trust Company
Pennsylvania
-$39.3K
4
HF
HRT Financial
New York
-$32K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$21.1K

BIVI Hedge Fund Activity: Q2 2026 in Review

36 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q2 2026, worth a combined $2.86M — up 98% from $1.44M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new BIVI positions and 3 closed out — a net gain of 3 holders — while 8 added to existing stakes and 11 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $833K. The largest seller was Diametric Capital, cutting an estimated $178K.

  • 36 institutional investors held BioVie (BIVI) as of Q2 2026, up from 33 in Q1 2026.
  • Funds reported $2.86M of BioVie stock for Q2 2026, up 98% quarter-over-quarter.
  • 6 funds opened new BioVie positions in Q2 2026 and 3 closed out, a net change of +3 holders.
  • The largest BioVie buyer in Q2 2026 was Morgan Stanley, an estimated $833K added.
  • The largest BioVie seller in Q2 2026 was Diametric Capital, an estimated $178K sold.

Based on aggregated 13F filings for Q2 2026.